Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
Meet NoDB, an open source Airtable alternative that builds REST endpoints and SDKs, so your team moves faster without monthly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback